Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years

NCT00372255 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00372255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years
Lead sponsor
GlaxoSmithKline
Phase
Phase 4
Overall status
Completed
Start date
November 17, 2005
Completion date
March 28, 2006
Enrollment
240 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

influenza